Search Results - james+hodge

1 Results Sort By:
Combination Cancer Therapy with HDAC Inhibitors
Abstract: The clinical promise of cancer immunotherapy relies on the premise that the immune system can recognize and eliminate tumor cells identified as non-self. The success of cancer immunotherapy is limited by tumor immune evasion, preventing long-lasting tumor control. Recent evidence suggests that certain anticancer therapies can alter the biology...
Published: 4/8/2024   |   Inventor(s): James Hodge, Sofia Gameiro
Keywords(s): Combination Therapy, CTL, HDAC inhibition, Immunotherapy
Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Oncology